Alcidion Group Ltd (ASX: ALC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Alcidion Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Alcidion Group Ltd (ASX: ALC)
Latest News
Share Gainers
Why Alcidion, Avita, BHP, & REA Group shares are storming higher
Share Gainers
Why the Alcidion (ASX:ALC) share price is shooting 38% higher today
Share Market News
Alcidion (ASX:ALC) share price storms higher on update
Share Gainers
Why Alcidion, Blackmores, Boral, & CogState shares are pushing higher
Speculative
3 exciting small cap ASX healthcare shares to watch
Share Market News
Alcidion share price drops despite FY20 revenue growth
Speculative
3 exciting small cap ASX shares to watch in FY 2021
Speculative
2 exciting small cap ASX shares to watch
Share Market News
3 quarterly updates you might have missed: Alcidion, Mach7, & Telix
Speculative
3 exciting small cap ASX shares to watch in August
Share Gainers
Why Alcidion, Bubs, IGO, & Next Science shares are pushing higher
Speculative
5 exciting small cap ASX shares to watch
Frequently Asked Questions
-
No, Alcidion does not pay dividends at this time.
-
Alcidion listed on the ASX on 24 June 2011.
ALC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Alcidion Group Ltd
Alcidion Group Ltd (ASX: ALC) is a provider of intelligent informatics software for the healthcare sector.
The company builds, sells, delivers, runs, and supports solutions for healthcare providers. These include clinical, analytical, managerial, and administrative systems.
Its products include its Miya suite, a Fast Healthcare Interoperability Resources (FHIR) system that allows comprehensive healthcare data to be exchanged between different computer systems. Other products include Smartpage and Patientrack software.
Alcidion derives the majority of its revenue from its Australia/New Zealand segment and also has a presence in the United Kingdom.
ALC Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
20 Dec 2024 | $0.06 | $0.00 | 0.00% | 2,350,536 | $0.06 | $0.06 | $0.06 |
19 Dec 2024 | $0.06 | $0.00 | 0.00% | 648,353 | $0.06 | $0.06 | $0.06 |
18 Dec 2024 | $0.06 | $0.00 | 0.00% | 2,262,046 | $0.06 | $0.06 | $0.06 |
17 Dec 2024 | $0.06 | $0.00 | 0.00% | 380,705 | $0.06 | $0.06 | $0.06 |
16 Dec 2024 | $0.06 | $0.00 | 0.00% | 1,309,908 | $0.06 | $0.06 | $0.06 |
13 Dec 2024 | $0.06 | $0.00 | 0.00% | 2,428,047 | $0.06 | $0.06 | $0.06 |
12 Dec 2024 | $0.06 | $0.00 | 0.00% | 1,516,256 | $0.06 | $0.06 | $0.06 |
11 Dec 2024 | $0.06 | $0.00 | 0.00% | 394,699 | $0.06 | $0.06 | $0.06 |
10 Dec 2024 | $0.06 | $0.00 | 0.00% | 131,252 | $0.06 | $0.06 | $0.06 |
09 Dec 2024 | $0.06 | $0.00 | 0.00% | 642,301 | $0.06 | $0.06 | $0.06 |
06 Dec 2024 | $0.06 | $0.00 | 0.00% | 347,725 | $0.06 | $0.06 | $0.06 |
05 Dec 2024 | $0.06 | $0.00 | 0.00% | 172,319 | $0.06 | $0.06 | $0.06 |
04 Dec 2024 | $0.06 | $0.00 | 0.00% | 1,845,830 | $0.06 | $0.06 | $0.06 |
03 Dec 2024 | $0.06 | $0.00 | 0.00% | 383,905 | $0.06 | $0.06 | $0.06 |
02 Dec 2024 | $0.06 | $0.00 | 0.00% | 664,282 | $0.06 | $0.06 | $0.06 |
29 Nov 2024 | $0.06 | $0.00 | 0.00% | 236,994 | $0.06 | $0.06 | $0.06 |
28 Nov 2024 | $0.06 | $0.00 | 0.00% | 916,836 | $0.06 | $0.07 | $0.06 |
27 Nov 2024 | $0.07 | $0.00 | 0.00% | 1,003,675 | $0.06 | $0.07 | $0.06 |
26 Nov 2024 | $0.07 | $0.00 | 0.00% | 1,973,768 | $0.07 | $0.07 | $0.06 |
25 Nov 2024 | $0.07 | $0.00 | 0.00% | 604,670 | $0.07 | $0.07 | $0.06 |
22 Nov 2024 | $0.06 | $0.00 | 0.00% | 1,235,628 | $0.07 | $0.07 | $0.06 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
26 Apr 2024 | Daniel Sharp | Transfer | 800,000 | $44,000 |
Off-market transfer. Assuming off market transfer of shares
|
26 Apr 2024 | Daniel Sharp | Transfer | 800,000 | $44,000 |
Off-market transfer. Assuming off market transfer of shares
|
26 Apr 2024 | Daniel Sharp | Buy | 250,000 | $13,070 |
On-market trade.
|
23 Apr 2024 | Katrina (Kate) Doyle (Quirke) | Transfer | 1,000,000 | $46,000 |
Off-market transfer. Assuming off market transfer of shares
|
23 Apr 2024 | Katrina (Kate) Doyle (Quirke) | Transfer | 1,000,000 | $46,000 |
Off-market transfer. Assuming off market transfer of shares
|
23 Apr 2024 | Katrina (Kate) Doyle (Quirke) | Buy | 1,000,000 | $46,671 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Ms Rebecca Jayne Wilson | Non-Executive DirectorNon-Executive Chairman | Jul 2017 |
Ms Wilson is a company director and Board advisor in Australia, UK and US and has more than 25 years of experience working within the healthcare, technology and life science sectors. She provides advice on complex stakeholder communication, issues management, investor and corporate relations, and business strategy to private and public companies, corporations, governments, and asset managers. She has mature governance and risk management experience.
|
Mr William (Bill) Smart | Non-Executive Director | Oct 2024 |
Mr Smart is a global digital health leader at both an operational and non-executive level having recently stepped down as the Global Director of External Relations, Dedalus Group, a global digital health company. Based in the United Kingdom, Will is currently Digital Non-Executive Director, Great Western Hospitals NHS Foundation Trust and was previously the CIO for Health and Social Care for England. He has held executive roles in several NHS Trusts including as Group Chief Information Officer, Royal Free London NHS Foundation Trust. In his capacity as Digital Non-Executive Director, Great Western Hospitals NHS Foundation Trust, Will is a member of the Acute Hospitals Alliance EPR Joint Committee responsible for overseeing the implementation of a new EPR across Great Western, Royal University Hospital, and Salisbury Trusts. Will is also a Director of CareTech Partners Limited providing digital advisory and consultancy support to public and private organisations and a member of the Health and Social Care Council at TechUK, a member organisation that represents and supports the UK technology sector and works with government, regulators and stakeholders.
|
Ms Victoria Weekes | Non-Executive Director | Sep 2021 |
Ms Weekes is a non-executive director with experience across a diverse range of industries built on a successful executive career in investment markets and financial services. Victorias 30 years of experience in the finance and banking sector includes Csuite roles as a Managing Director at Citigroup and Executive General Manager at Westpac. As the immediate past Chair of the Sydney Local Health District, Victoria has a deep understanding of the healthcare sector where she served as Chair of its Education & Research Committee and Deputy Chair. She is the chairman of risk committee.
|
Ms Katrina (Kate) Elizabeth Doyle (Quirke) | Chief Executive OfficerExecutive DirectorManaging Director | Jul 2018 |
Ms Doyle has been CEO of Alcidion since 2018, prior to which she was CEO of MKM Health until it was acquired by Alcidion. She has been involved in large systems procurements and implementations of healthcare information technology across Australia, United Kingdom, New Zealand and Southeast Asia. Her background involves holding leading management roles at some of the largest healthcare software firms where she has had an impact on strategic product direction across
the health sector and believes astute application of information technology will support the transformation of healthcare delivery worldwide. |
Mr Daniel Sharp | Non-Executive Director | Sep 2021 |
Mr Sharp has over 25 years senior executive experience in investment banking and corporate finance. From 2012-2020, Daniel was an Executive Director of Corporate Finance at Canaccord Genuity where he led dozens of equity capital market transactions and corporate finance advisory projects across the healthcare, life sciences, technologies, financial services and general industrials sectors. Prior to his executive role at Canaccord, Daniel headed the corporate finance division at two of Australia's independent Investment Banking/Stockbroking firms. He is closely connected to strong networks of institutional, family office and high net worth investors both in Australia and overseas. He is also a member of risk committee.
|
Mr Michael Sapountzis | Company Secretary | Mar 2019 |
-
|
Matthew Gepp | Chief Financial Officer |
-
|
|
Michael Sapountzis | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
J P Morgan Nominees Australia Pty Limited | 156,589,750 | 11.66% |
Mr Malcolm Pradhan | 134,582,403 | 10.02% |
Bond Street Custodians Limited <Salter D79836 A/C> | 73,000,000 | 5.44% |
Mr Raymond Howard Blight | 68,801,020 | 5.12% |
Rewmicman Pty Ltd <Smallman Family A/C> | 28,810,441 | 2.15% |
Mrs Katrina Elizabeth Doyle | 27,793,199 | 2.07% |
Caledonia Nominees Pty Ltd <Caledonia A/C> | 19,976,377 | 1.49% |
MNMD Pty Ltd <Quirke Super Fund A/C> | 19,668,086 | 1.47% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 17,189,236 | 1.28% |
Bond Street Custodians Limited <RSALTE - D62375 A/C> | 13,999,000 | 1.04% |
Mr Dean Anthony Mackenzie | 13,143,801 | 0.98% |
Mr Paul John Van Dyk | 12,300,000 | 0.92% |
Sandhurst Trustees Ltd <Cyan C3G Fund A/C> | 10,469,114 | 0.78% |
Citicorp Nominees Pty Limited | 10,272,574 | 0.77% |
Rangiora London Pty Limited <Rangiora-London A/C> | 7,800,000 | 0.58% |
Emerald Shares Pty Limited <Emerald Unit A/C> | 7,100,000 | 0.53% |
Mr Vivek Ramakrishnan and Miss Nisha Srinivasan | 7,021,913 | 0.52% |
Finclear Services Pty Ltd <Superhero Securities A/C> | 6,807,539 | 0.51% |
Hudson Retirement Pty Ltd <Seagulls Super A/C> | 6,524,244 | 0.49% |
Webzone Holdings Pty Ltd | 5,820,000 | 0.42% |